Le Lézard
Classified in: Health
Subject: SVY

Fabry Disease - Epidemiology Forecast to 2025


NEW YORK, Nov. 17, 2017 /PRNewswire/ -- DelveInsight's "Fabry Disease -Epidemiology Forecast, 2025" provides an overview of the epidemiology trends of Fabry Disease in seven major markets (US, France, Germany, Italy, Spain, UK and Japan).

Read the full report: https://www.reportlinker.com/p05144670

It includes 10 years epidemiology historical and forecasted data of Insulin Resistance. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical needs associated with the Insulin Resistance. The report contains the targeted patient populations and the forecast methodology.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by DelveInsight team of industry experts.

Key Coverage and Benefits
? The Report includes the prevalent population and how will it change over the next eight years.
? Coverage of key Fabry Disease sub-populations and its prevalent or incident cases
? Prevalent or incident cases segmented by age and sex.
? The key differences in epidemiology patterns across the seven market segments.

Reasons to buy
? Developing business strategies by understanding the trends shaping and driving the global Fabry Disease market.
? Identifying prevalent patient populations as well as risk factors in the global Fabry Disease market will help to improve product design, pricing, and launch plans.
? Organize sales and marketing efforts by identifying the best opportunities for Fabry Disease therapeutics in each of the markets covered.

Read the full report: https://www.reportlinker.com/p05144670

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker


These press releases may also interest you

at 06:31
Hangzhou Tigermed Consulting Co., Ltd. ("Tigermed" or the "company") (Stock code: 300347.SZ / 3347.HK), a leading global provider of integrated research and development solutions for biopharmaceutical and medical device industry, announced its annual...

at 06:30
Caris Life Sciences®(Caris), the leading next-generation AI TechBio company and precision medicine pioneer that is actively developing and delivering innovative solutions to revolutionize healthcare and improve the human condition using molecular...

at 06:30
The collagen water market is booming thanks to the growing popularity of health and beauty products. Consumers are more interested in skincare and healthy eating, which is driving manufacturers to create collagen-infused drinks and cosmetics. A new...

at 06:30
Viavi Solutions Inc. (VIAVI)  today announced it has participated in the 2024 RIC Forum, March 26-28, in Dallas, Texas. The company contributed its TeraVM RIC Test and TM500 Network Tester to multiple demonstrations, building on collaborations at MWC...

at 06:30
Three clinical programs present diversified opportunities in and outside the existing anti-VEGF market and are being progressed toward Phase 3 value inflection points  New Phase 3 GLOW2 study of tarcocimab in diabetic retinopathy actively...

at 06:30
The "PCR Markets. Forecasts for qPCR, dPCR, Singleplex & Multiplex Markets and by Application, Product and Place. With Executive and Consultant Guides, Including Customized Forecasting and Analysis. 2023 to 2027" report has been added to...



News published on and distributed by: